We selected HPMECs as a representative endothelial cell because of the lung pathology associated with COVID-19 and because they do not endogenously express ACE2 and are not permissive to SARS-CoV-2 infection, thus allowing us to separate viral infection from S-mediated barrier dysfunction (Fig. S1A, B). This evidence concerns the gene ACE2 and viral infectious disease.